Home/Protocols/Sermorelin
Protocol Reference
Human trial data

Sermorelin protocol

Sermorelin (GHRH 1-29 analog). Dosing on this page comes from a published human trial or an approved product label, cited below.

Category
Growth Hormone Axis
Common vials
5, 10 mg
Half-life
Short — roughly 10–20 minutes
Route in the literature
Subcutaneous
Evidence level
Human trial data

How Sermorelin works

The first 29 amino acids of growth-hormone-releasing hormone, which is the shortest fragment retaining full activity. It stimulates the pituitary to release its own growth hormone, so output stays under normal feedback control rather than bypassing it as injected hGH does.

Sermorelin dosing schedule

From the approved label for sermorelin acetate, which was marketed as Geref for growth failure in children with growth-hormone deficiency. It was withdrawn from the US market in 2008 for commercial reasons rather than safety findings. Note the indication: this schedule was established in growth-hormone-deficient children, not in healthy adults.

PhaseAmountFrequencyNotes
Approved paediatric use0.03 mg/kgOnce daily at bedtime, subcutaneousFrom the Geref label. Bedtime timing aligns with the natural nocturnal GH pulse.
Diagnostic use1 mcg/kgSingle intravenous doseSermorelin was also used as a single-dose pituitary function test.

Study length: Continued until growth plates closed or growth response ceased, in the paediatric indication.

Source for this schedule: Sermorelin acetate (Geref) prescribing information, idiopathic growth hormone deficiency indication. This reproduces what was administered in that work. It is reference information about a study, not a recommendation, and the trial population, monitoring and endpoints are part of what made it a protocol.

Reconstitution and measurement

This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for Sermorelin: 5, 10 mg.

Open the Sermorelin calculator → Unit converter

Storage and stability

Dry powder
Cold, dark and dry. Lyophilized peptide is the stable form — keep it that way until you intend to use it.
After reconstitution
Refrigerate at 2–8 °C, protect from light, and plan around a limited window. Do not freeze a reconstituted vial — freeze-thaw damages peptides.
Mixing
Run bacteriostatic water down the inside wall of the vial rather than onto the powder, then swirl. Never shake.
Inspect before use
A clear solution is expected. Cloudiness or particles mean discard, not use.

Full storage guide → · Cloudy solution?

Reported effects

  • The label reported injection-site reactions as the most common adverse event, at roughly one in six patients.
  • Flushing, headache and dysphagia were reported less frequently.
  • Because it works through the pituitary, feedback regulation is preserved — a mechanistic difference from exogenous hGH.

Sourcing Sermorelin

Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.

Sermorelin at Summit Research Supply → Grade a COA first

Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.

For laboratory research use only. This page documents what the published literature reports about Sermorelin. It is not a recommendation, not a treatment plan, and not medical advice. Compounds referenced are sold strictly as research chemicals and are not for human or veterinary use. Some supplier links are affiliate links and may earn us a commission. This never affects tier placement or review conclusions.
Summit Research Supply
Summit Research Supply — COA-verified research peptidesThird-party tested · U.S. fulfillment · new researchers save 10%
Shop →